Computational screening and evaluation of bioactive compounds against NS3 helicase of HCV

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 5, Issue 4, 2013, Pages 370-376

  Arumugam, Mohanapriya ^a   Lulu, Sajitha ^a   Kumari, Sweta ^a   Kumari, Nancy Veena D ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Hepatitis C virus; Non structural proteins; NS3; Tinosporide

Indexed keywords

ANDROGRAPHOLIDE; ANTIVIRUS AGENT; ARJUNGENIN; ARJUNIC ACID; BERBERINE; CHASMANTHIN; COLUMBIN; DESMETHYL WEDELOLACTONE; ESCULETIN; FRIEDELIN; GOSSYPINE; HYPERICIN; HYPEROFORIN; HYPOPHYLLANTHIN; JATRORRHIZINE; KUTKOSIDE; LIGAND; NONSTRUCTURAL PROTEIN 3; PHYLLANTHIN; PICROSIDE I; PLANT MEDICINAL PRODUCT; PSEUDOHYPERICIN; SILYMARIN; SITOSTEROL; SWERTININ; THALIPORPHINE; TINOSPORIDE; UNCLASSIFIED DRUG; WEDELOLACTONE;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING SITE; BIOLOGICAL ACTIVITY; COMPUTER SIMULATION; DRUG SCREENING; DRUG STABILITY; HEPATITIS C; HEPATITIS C VIRUS; MEDICINAL PLANT; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; NONHUMAN; PHYTOCHEMISTRY; PROBABILITY; PROTEIN DATA BANK; PROTEIN STRUCTURE; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 84885355560     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Pandey Govind. Medicinal Plants against Liver Diseases, International Research Journal Of Pharmacy 2011; 2 (5): 115-121.
2. Ravikumar YS, Nandhitha M, Raja Naika H, Saumitra Das and Upasna Ray. Inhibition of Hepatitis C Virus replication by herbal extract: Phyllanthus amarus as potent natural source. Virus Research 2011; 158: 89-97.
3. Colin WS, Lyn Finelli, Miriam J Alter. Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases 2005; 5: 558-67.
4. Srinivasan P, Sudha A, Shahul Hameed A, Prasanth Kumar S and Karthikeyan M. Screening of medicinal plant compounds against NS5B polymerase of hepatitis C virus (HCV) using molecular docking studies. Journal of Pharmacy Research 2011; 4(1): 136-140.
5. Rudolf K. F. Beran, Victor Serebrov, and Anna Marie Pyle. The Serine Protease Domain of Hepatitis C Viral NS3 Activates RNA Helicase Activity by Promoting the Binding of RNA Substrate. The Journal of Biological Chemistry 2007; 282(48): 34913-34920.
6. Arnaz Ranji and Kathleen Boris-Lawrie. RNA helicases: Emerging roles in viral relication and the host innate response. RNA Biology 2010; 7(6): 775-787.
7. Arnim Pause, George Kukolj, Murray Bailey, Martine Brault, Florence Dô, Ted Halmos, et al. An NS3 Serine Protease Inhibitor Abrogates Replication of Subgenomic Hepatitis C Virus RNA. Journal of Biological Chemistry 2003; 278: 20374-20380.
8. Meenaa V, Kavitha SrilakshmiJ, Sriram S, Sasikumar C. NS5B RNA Dependent RNA Polymerase as Drug Target against Hepatitis C Virus-An insilico study. Advanced Biotechnology 2011; 1(3): 3-5.
9. Salna KP, Sreejith K, Uthiralingam M, Mithu AP, John Milton MC, and Albin TF. A comparative Study of Phytochemicals Investigation of Andrographis Paniculata and Murraya Koenigii. International Journal of Pharmacy and Pharmaceutical Sciences 2011; 3(3): 291-292.
10. Meredith Ayers. ChemSpider: The Free Chemical Database. Reference Reviews 2012; 26(7): 45-46.
11. Sadowski J, Gasteiger J, Klebe G. Comparison of Automatic Three-Dimensional Model Builders Using 639 X-Ray Structures. J. Chem. Inf. Comput. Science 1994; 34: 1000-1008.
12. Morris GM., Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. Journal of Computational Chemistry 2009; 16: 2785-91.
13. Berendsen HJC, van der Spoel D, van Drunen R. GROMACS: A message-passing parallel molecular dynamics implementation, Computer Physics Communications 1995; 91(1-3): 43-56.
14. Erik Lindahl, Berk Hess, David van der Spoel. GROMACS 3. 0: a package for molecular simulation and trajectory analysis, Journal of Molecular Modeling 2001; 7(8): 306-317.
15. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: Fast, flexible, and free. Journal of Comput. Chemistry 2005; 26(16): 1701-18.
16. Berk Hess, Carsten Kutzner, Van Der Spoel D, Erik Lindahl. GROMACS 4: Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. J. Chem. Theory Computation 2008; 4(3): 435-447.
17. Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. J Comb Chemistry 1999; 1 (1): 55-68.
18. Alexey Lagunin, Alla Stepanchikova, Dmitrii Filimonov and Vladimir Poroikov. PASS: prediction of activity spectra for biologically active substances. Bioinformatics 2000; 16 (8): 747-748.
19. Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. Journal Medical Chemistry 2000; 43: 3714-3717.
20. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Delivery Reviews 1997; 23: 4-25.
21. Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medical Chemistry 2002; 45: 2615-2623.
22. Sheeba Rani M, Emmanuel S, Raja Sreekanth M and Ignacimuthu S. Evaluation of In vivo Antioxidant and Hepaprotective Activity of Cassia Occidentalis Linn. Against Paracetamol-Induced Liver Toxicity in Rats. International Journal of Pharmacy and Pharmaceutical Sciences 2010; 2(3): 67-70.
23. Accelrys Software Inc., Discovery Studio Modeling Environment, Release 3. 5, San Diego: Accelrys Software Inc. 2012.